Detalles de la búsqueda
1.
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Proc Natl Acad Sci U S A
; 114(2): 370-375, 2017 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28011764
2.
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses.
Curr Med Chem
; 31(10): 1289-1295, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37143268
3.
New 1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2H)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other Diseases.
Recent Pat Anticancer Drug Discov
; 19(2): 253-255, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-36852816
4.
Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome.
Front Pharmacol
; 15: 1337436, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410131
5.
Novel 1,4-Dihydropyrido[2,3-B]Pyrazine-2,3-Dione Derivatives for Treating Cancer and Other Disorders Associated with KRAS Activity.
Anticancer Agents Med Chem
; 23(8): 979-980, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36443974
6.
Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitor for the Treatment of Atopic Dermatitis.
Curr Med Chem
; 30(38): 4278-4282, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36797599
7.
Novel 2,4- diaminopyrimidine 5-carboxamides as c-Jun N-terminal Kinase Inhibitors for Treating the Liver Fibrotic Disorder.
Endocr Metab Immune Disord Drug Targets
; 23(8): 1118-1123, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36803749
8.
Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal Candidiasis.
Curr Med Chem
; 30(37): 4170-4175, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36803759
9.
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and Other Diseases.
Curr Med Chem
; 2023 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37493157
10.
Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases.
Recent Pat Anticancer Drug Discov
; 18(4): 549-551, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36476427
11.
Novel Proline Derivatives for Treating COVID-19.
Curr Med Chem
; 30(12): 1458-1461, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36154584
12.
Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases.
Curr Med Chem
; 2023 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259937
13.
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer.
Curr Med Chem
; 2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37231730
14.
First Approval of Elacestrant as a Selective Estrogen Receptor Degrader for the Treatment of Metastatic Breast Cancer.
Curr Med Chem
; 2023 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37143269
15.
Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer.
Anticancer Agents Med Chem
; 23(14): 1697-1700, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37157195
16.
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults.
Curr Med Chem
; 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37818564
17.
New Pyrrolopyrimidines as LRRK2 Inhibitors for Treating Parkinson's Disease.
Curr Med Chem
; 2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37605404
18.
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis.
Anticancer Agents Med Chem
; 23(12): 1355-1360, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959157
19.
Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.
Bioorg Med Chem
; 19(8): 2582-8, 2011 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21458276
20.
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site.
Proc Natl Acad Sci U S A
; 105(43): 16809-13, 2008 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-18922779